MDT

89.7

-0.3%↓

VEEV

281.39

+2.01%↑

A

120.9

-1.95%↓

WBA

11.52

+0.09%↑

HQY

94.85

+0.42%↑

MDT

89.7

-0.3%↓

VEEV

281.39

+2.01%↑

A

120.9

-1.95%↓

WBA

11.52

+0.09%↑

HQY

94.85

+0.42%↑

MDT

89.7

-0.3%↓

VEEV

281.39

+2.01%↑

A

120.9

-1.95%↓

WBA

11.52

+0.09%↑

HQY

94.85

+0.42%↑

MDT

89.7

-0.3%↓

VEEV

281.39

+2.01%↑

A

120.9

-1.95%↓

WBA

11.52

+0.09%↑

HQY

94.85

+0.42%↑

MDT

89.7

-0.3%↓

VEEV

281.39

+2.01%↑

A

120.9

-1.95%↓

WBA

11.52

+0.09%↑

HQY

94.85

+0.42%↑

Search

Actinium Pharmaceuticals Inc

Gesloten

1.49 -3.87

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.48

Max

1.53

Belangrijke statistieken

By Trading Economics

Inkomsten

-9.3M

-16M

Werknemers

31

EBITDA

-9.3M

-17M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+294.74% upside

Dividenden

By Dow Jones

Volgende Winsten

1 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.4M

45M

Vorige openingsprijs

5.36

Vorige sluitingsprijs

1.49

Actinium Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 jul 2025, 22:19 UTC

Acquisities, Fusies, Overnames

FCC Approves U.S. Cellular Sale to T-Mobile

11 jul 2025, 17:28 UTC

Belangrijke Marktbewegers

SharpLink Gaming Gains on Ethereum Purchase

11 jul 2025, 16:57 UTC

Winsten

BASF Cuts Outlook on Global Economy Uncertainty

13 jul 2025, 23:54 UTC

Marktinformatie

Oil Edges Higher Amid Supply Disruption Worries -- Market Talk

13 jul 2025, 23:49 UTC

Marktinformatie

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

13 jul 2025, 23:49 UTC

Marktinformatie

Global Equities Roundup: Market Talk

13 jul 2025, 23:40 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

13 jul 2025, 23:40 UTC

Marktinformatie

Gold Advances Amid Rising Trade Tensions -- Market Talk

13 jul 2025, 23:39 UTC

Marktinformatie

China's Growth Momentum Likely Slowed in 2Q -- Market Talk

13 jul 2025, 23:16 UTC

Winsten

China Shenhua Energy 1H 2024 Net Was CNY32.8B>1088.HK

13 jul 2025, 23:16 UTC

Winsten

China Shenhua Energy: Drop in Coal Prices Weighed on Results >1088.HK

13 jul 2025, 23:16 UTC

Winsten

China Shenhua Energy Sees 1H Net CNY25.6B-Net CNY27.6B >1088.HK

13 jul 2025, 23:13 UTC

Marktinformatie

Global Equities Roundup: Market Talk

13 jul 2025, 23:13 UTC

Marktinformatie

Ryman Healthcare Could Be Turning a Corner -- Market Talk

13 jul 2025, 11:00 UTC

Acquisities, Fusies, Overnames

The Private-Equity Maneuver Allowing More Investors to Cash Out -- WSJ

12 jul 2025, 02:24 UTC

Acquisities, Fusies, Overnames

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

12 jul 2025, 02:05 UTC

Acquisities, Fusies, Overnames

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

12 jul 2025, 02:05 UTC

Acquisities, Fusies, Overnames

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

12 jul 2025, 02:05 UTC

Acquisities, Fusies, Overnames

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

11 jul 2025, 21:45 UTC

Marktinformatie

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 jul 2025, 19:46 UTC

Acquisities, Fusies, Overnames

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 jul 2025, 19:45 UTC

Marktinformatie

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 jul 2025, 19:05 UTC

Marktinformatie

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 jul 2025, 18:18 UTC

Marktinformatie

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 jul 2025, 17:35 UTC

Marktinformatie

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 jul 2025, 17:26 UTC

Marktinformatie

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 jul 2025, 16:53 UTC

Marktinformatie

Crude Futures Add to Early Gains -- Market Talk

11 jul 2025, 16:42 UTC

Winsten

BASF Cuts Outlook on Global Economic Uncertainty

11 jul 2025, 16:08 UTC

Marktinformatie

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 jul 2025, 16:05 UTC

Winsten

BASF Will Publish Half-Year Results on July 30

Peer Vergelijking

Prijswijziging

Actinium Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

294.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6 USD  294.74%

Hoogste 9 USD

Laagste 4 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Actinium Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.